More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$48.08B
EPS
1.43
P/E ratio
145
Price to sales
2.15
Dividend yield
--
Beta
-0.478571
Previous close
$35.93
Today's open
$35.88
Day's range
$35.88 - $36.87
52 week range
$31.49 - $50.88
show more
CEO
--
Employees
43000
Headquarters
Northfield, IL
Exchange
Nasdaq Global Select
Shares outstanding
1.31B
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
MDLN Securities Announcement: Medline Investors with Losses may have Rights in an Ongoing Securities Fraud Investigation – Contact BFA Law
NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.
GlobeNewsWire • an hour ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
PRNewsWire • a day ago

Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
State-of-the-art facility planned to reinforce Medline's supply chain resilience in Michigan NORTHFIELD, Ill., Oct. 15, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, has announced plans to open a new distribution center in Van Buren Township, Mich.
PRNewsWire • 17 hours ago

$MDLN Investors: A Securities Fraud Investigation is Pending on behalf of Medline Investors that Lost Money after 13% Stock Drop – Contact BFA Law
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.
GlobeNewsWire • Oct 14, 2026

Medline Inc. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your MDLN Investments
New York, New York--(Newsfile Corp. - October 13, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened?
Newsfile Corp • Oct 13, 2026

MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors
BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Oct. 13, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ: MDLN) for potential securities fraud after its significant stock drops.
PRNewsWire • Oct 13, 2026

Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
Combines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibility NORTHFIELD, Ill., Oct. 12, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) today announced the launch of an enhanced version of TrackPoint™, its online inventory management and patient item usage solution designed to help long-term care and inpatient hospice providers more easily track supplies from Medline, capture patient-level usage and gain visibility into inventory across locations.
PRNewsWire • Oct 12, 2026

MDLN Securities Alert: Lose Money on Your Medline Investment? BFA Law Notifies Investors of the Ongoing Securities Fraud Investigation over Product Quality Issues
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.
GlobeNewsWire • Oct 9, 2026

MDLN ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Potential Securities Law Violations
New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.
Newsfile Corp • Oct 8, 2026

MDLN Investor Reminder: BFA Law Reminds Medline Investors that Lost Money when Stock Dropped 13% of the Ongoing Securities Fraud Investigation
NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.
GlobeNewsWire • Oct 7, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Medline Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.